PALAZZOLO, LUCA
 Distribuzione geografica
Continente #
AS - Asia 6.166
EU - Europa 6.115
NA - Nord America 5.989
SA - Sud America 543
AF - Africa 144
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.009
Nazione #
US - Stati Uniti d'America 5.800
CN - Cina 1.912
SG - Singapore 1.895
IT - Italia 1.884
DE - Germania 1.078
GB - Regno Unito 1.006
VN - Vietnam 529
HK - Hong Kong 523
SE - Svezia 491
BR - Brasile 416
RU - Federazione Russa 371
IN - India 294
FR - Francia 293
BD - Bangladesh 245
JP - Giappone 206
NL - Olanda 191
KR - Corea 145
ID - Indonesia 142
FI - Finlandia 133
IE - Irlanda 125
DK - Danimarca 123
CA - Canada 103
BE - Belgio 71
AT - Austria 54
CI - Costa d'Avorio 52
TR - Turchia 51
CH - Svizzera 48
PL - Polonia 46
MX - Messico 44
AU - Australia 43
AR - Argentina 41
ES - Italia 41
IQ - Iraq 26
TW - Taiwan 26
UA - Ucraina 26
EC - Ecuador 24
PK - Pakistan 22
PT - Portogallo 22
IR - Iran 21
CZ - Repubblica Ceca 20
GR - Grecia 19
ZA - Sudafrica 19
PH - Filippine 18
CO - Colombia 16
NO - Norvegia 16
TN - Tunisia 15
VE - Venezuela 15
EG - Egitto 14
TH - Thailandia 13
MY - Malesia 12
UZ - Uzbekistan 12
CR - Costa Rica 11
MA - Marocco 10
CL - Cile 9
SC - Seychelles 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
SA - Arabia Saudita 8
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
BG - Bulgaria 6
IL - Israele 6
LT - Lituania 6
LU - Lussemburgo 6
PE - Perù 6
PY - Paraguay 6
SI - Slovenia 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
HR - Croazia 4
KW - Kuwait 4
LK - Sri Lanka 4
NI - Nicaragua 4
OM - Oman 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
BY - Bielorussia 3
GE - Georgia 3
LB - Libano 3
NG - Nigeria 3
NP - Nepal 3
RS - Serbia 3
BN - Brunei Darussalam 2
BS - Bahamas 2
CM - Camerun 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GD - Grenada 2
GH - Ghana 2
HN - Honduras 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 18.979
Città #
Singapore 1.112
Southend 769
Milan 746
Ashburn 723
Frankfurt am Main 591
Hong Kong 455
Dallas 379
San Jose 371
Beijing 278
Fairfield 267
Chandler 261
Council Bluffs 229
Hefei 226
Hanoi 223
Wilmington 205
Seattle 170
Los Angeles 169
Cambridge 160
Ann Arbor 154
Houston 140
Santa Clara 131
Woodbridge 131
New York 130
Ho Chi Minh City 123
Dublin 122
Princeton 117
Redwood City 112
Bengaluru 109
Dearborn 109
Jakarta 98
Tokyo 96
Hanover 90
Lauterbourg 86
Seoul 84
Moscow 78
Shanghai 75
The Dalles 73
Guangzhou 70
Helsinki 69
Nanjing 69
Buffalo 63
Rome 62
Munich 59
Phoenix 54
Abidjan 52
Grafing 52
Boardman 46
Cangzhou 41
Des Moines 39
Chicago 37
Columbus 36
Amsterdam 35
Naples 33
Medford 31
Vienna 30
Berlin 28
Tianjin 28
Jinan 27
Nuremberg 27
São Paulo 27
Dong Ket 26
Ponte San Pietro 26
Shenyang 26
Warsaw 26
Montreal 25
Changsha 24
Hebei 24
Istanbul 23
Hangzhou 21
Nanchang 21
Brussels 20
Shenzhen 20
Bologna 19
Lappeenranta 19
London 19
Orem 19
Wuhan 19
Cinisello Balsamo 18
Düsseldorf 18
Melbourne 18
Rho 18
Toronto 18
Zhengzhou 18
Boston 17
Turku 17
Braine-l'Alleud 16
Chengdu 16
Liège 16
Turin 16
Basingstoke 15
Bühl 15
Da Nang 15
Fuzhou 15
Washington 15
Belo Horizonte 14
Mumbai 14
San Diego 14
Wroclaw 14
Bari 13
Bergamo 13
Totale 11.147
Nome #
With or without you - Proteomics with or without major plasma/serum proteins 635
DEVELOPMENT OF AN INTEGRATED IN SILICO STRATEGY FOR THE RISK ASSESSMENT OF CHEMICALS AND THEIR MIXTURES ON DIFFERENT TOXICOLOGICAL OUTCOMES. 468
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5) : probing critical residues for substrate translocation 416
SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure 412
Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligand 404
Comparison of Protein Design Tools For Engineering Non-heme Iron Dependent Dioxygenases 382
A promiscuous recognition mechanism between GPR17 and SDF-1 : molecular insights 364
A new strategy of selective Notch receptor targeting in multiple myeloma based on small molecules 330
Enzymatic reduction of acetophenone derivatives with a benzil reductase from Pichia glucozyma (KRED1-Pglu): electronic and steric effects on activity and enantioselectivity 323
In silico description of LAT1 transport mechanism at an atomistic level 301
Development of an adverse outcome pathway for cranio-facial malformations: A contribution from in silico simulations and in vitro data 298
2,4-Furfurylidene-D-sorbitol and its tetra-methyl ether: Synthesis, conformational studies, and radical scavenging activity 290
Deciphering remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties : An in silico approach 282
Set-up and validation of a high throughput screening method for human monoacylglycerol lipase (MAGL) based on a new red fluorescent probe 280
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease 275
A new therapeutic strategy in multiple myeloma based on small molecules directed to notch pathway 271
Mechanism of LAT1 amino acid antiport: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 264
Deciphering and modelling remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties 263
rHDL modelling and the anchoring mechanism of LCAT activation 263
Notch-targeted therapeutic strategy in multiple myeloma based on small molecules hampering receptor-ligand interaction 258
Structural investigation and molecular modeling studies of strobilurin-based fungicides active against the rice blast pathogen Pyricularia oryzae 257
Molecular Modelling of NONO and SFPQ Dimerization Process and RNA Recognition Mechanism 251
Computational modelling of the LCAT::rHDL complex and bases of LCAT pharmacological activation 246
Atomistic description of the OCTN1 recognition mechanism via in silico methods 245
Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase 244
Comparison of teratogenic potency of azoles using in silico and in vitro methods 241
What if? Mouse proteomics after gene inactivation 237
Predicting estrogen receptor binding of chemicals using a suite of in silico methods – Complementary approaches of (Q)SAR, molecular docking and molecular dynamics 235
Gender proteomics. II. Which proteins in sexual organs 232
GPR17 molecular modelling: interactions with non-conventional pro-inflammatory ligands 228
Targeting the interaction of multiple myeloma and the bone marrow microenvironment through novel small molecules directed to Notch pathway 221
Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New Evidence 217
Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells 217
Distinguishing mode of action of compounds inducing craniofacial malformations in zebrafish embryos to support dose-response modeling in combined exposures 216
Discovery and characterization of a new class of NAD+-independent SIRT1 activators 215
Mechanism of LAT1 amino acid antiport: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 215
Hemolymph proteins: An overview across marine arthropods and molluscs 214
In silico investigation on structure–function relationship of members belonging to the human SLC52 transporter family 208
Exploration of Novel Scaffolds Targeting Cytochrome b of Pyricularia oryzae 208
In silico prioritization of endocrine active substances (EAS) and their in vitro validation 207
Mechanism of LAT1 amino acid antiporter: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 206
Development of an integrated system biology model for predicting mixtures of chemicals: the case of the azole fungicides 206
Deciphering the ligand/xenobiotic molecular recognition mechanism in SLC transporters via a new structural binding site analysis 200
Crystal structure and functional characterization of the GPR17 receptor, a novel pharmacological target for remyelination therapy in multiple sclerosis 198
Analisi geofisica integrata per la caratterizzazione della micrometeorologia ipogea 195
Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder 192
Effect of Fc core fucosylation and light chain isotype on IgG1 flexibility 189
Modellng Molecolare e meccanismo di interazione del complesso LCAT-rHDL 189
SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability 188
In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3 184
Supramolecular modeling of an LCAT-rHDL assembly and cholesterol transesterification mechanism 184
Investigation of in silico studies for cytochrome P450 isoforms specificity 179
GM1 structural requirements to mediate neuronal functions 175
Gender proteomics I. Which proteins in non-sexual organs 175
Predicting Estrogen receptor binding of chemicals using a suite of in silico methods : complementary approaches of (Q)SAR, Molecular Docking and Molecular Dynamics 175
Valutazione in silico dell’attività tossica di beta-insect depressant toxin LqhIT2 prodotta da Leiurus hebraeus sui canali voltaggio- dipendenti del sodio di Homo Sapiens 174
A new strategy for selective NOTCH2 targeting in multiple myeloma based on small molecules hampering receptor-ligand interaction 174
In silico Investigation on Structure–Function Relationship of Members Belonging to the Human SLC52 Transporter Family 168
In silico description of OCTN1 recognition mechanism and the role of sodium in substrate binding 167
In silico prioritization for endocrine active substances (EAS) and their in vitro validation 166
Some more about dogs: Proteomics of neglected biological fluids 166
Literature search – Exploring in silico protein toxicity prediction methods to support the food and feed risk assessment 163
Differential skeletal preservation between sexes: a diachronic study in Milan over 2000 years 162
Supramolecular modelling of an LCAT-rHDL assembly and cholesterol trans- esterification mechanism 159
From Protein Toxins to Applied Toxicological Testing 159
In Silico Prediction Tools for Cytochrome P450 Isoform Specificity: A Comprehensive Review and Model Evaluation 155
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 155
The diachronic trend of female and male stature in Milan over 2000 years 154
In silico investigation of mAbs conformational changes upon antigen binding: impact of glycosylation and light chain isotype 153
Development of in silico methodologies to predict the toxicity of novel proteins in the context of food and feed risk assessment 151
In silico identification of small molecules engaging the TNFR2-TNF-α interaction: a novel approach for targeting demyelinating diseases 147
Insights into the EFSA protein risk assessment: in silico tools : Protein toxicity: an integrated in silico pipeline 147
New Notch-targeted therapeutic strategy to uncouple a pathological interaction of myeloma cells and bone marrow microenvironment using novel small molecules 145
In silico prediction of ANGPTL3-endothelial lipase interaction 142
Supramolecular modelling of an LCAT-rHDL assembly and cholesterol trans- esterification mechanism 139
An in silico integrated pipeline for affinity and intrinsic activity evaluation of estrogen receptor alpha putative ligands 137
In silico identification of small molecules engaging the TNFR2-TNF-α interaction: a novel approach for targeting demyelinating diseases 132
L'approccio in silico 131
Sviluppo e validazione di una pipiline integrata in silico per la determinazione di affinità e attività intrinseca di xenobiotici sul recettore alfa degli estrogeni 131
In silico description of OCTN1 recognition mechanism and the role of sodium in substrate binding 129
Predicting estrogen receptor binding of chemicals using a suite of in silico methods-complementary approaches of (Q)Sar, molecular docking and molecular dynamics 127
Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs 118
Biological and molecular characterization of in silico identified putative inhibitors of paraspeckle assembly with potential anti-multiple myeloma activity 115
Structure-activity and molecular modeling studies of strobilurin-based dual fungicides for the control of rice blast pathogen Pyricularia oryzae 113
LAT1, a pivotal actor on cancer stage: when function meets structure 108
Modelli QSAR e Approcci Read-Across: Strumenti Fondamentali per la Valutazione del Rischio 104
In silico prediction of ANGPTL3-EL interaction 99
Strategie in silico di predizione di tossicità applicate alle proteine 99
AOP-based experimental models to evaluate effects of azole mixtures 92
From Protein Toxins to Applied Toxicological Testing Virtual Workshop Identifies the Need for a Bioinformatic Framework to Assess Novel Food Protein Safety 92
Protective and reparative effects of fluconazole on neuronal differentiation altered by 5HT 90
A new "old" model: PBPK 88
Stato dell'arte sugli strumenti in silico per la predizione di tossicità di proteine 82
Ragionare è nient'altro che calcolare 80
La fisica degli archivi del tempo 71
Development of a predictive in silico model for mixtures of azole fungicides acting on the skeletal craniofacial AOP 71
Tutti i modelli sono sbagliati, ma alcuni sono utili 65
Exercise with PB-PK models 50
Crystal structure and functional characterization of the GPR17 receptor, a novel pharmacological target for remyelination therapy in multiple sclerosis 49
null 6
Totale 19.693
Categoria #
all - tutte 56.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.857


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021255 0 0 0 0 0 0 0 0 0 0 71 184
2021/20221.336 130 86 100 98 73 93 78 73 76 131 136 262
2022/20231.430 187 107 107 122 128 223 68 116 155 47 105 65
2023/20241.922 66 105 235 245 312 74 144 153 65 127 170 226
2024/20253.759 181 383 164 347 280 150 215 369 195 331 321 823
2025/20267.074 703 640 822 700 637 402 905 311 739 495 720 0
Totale 19.696